Download PDF
Thromb Haemost 1966; 15(01/02): 012-028
DOI: 10.1055/s-0038-1649408
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

A Clinical and Laboratory Study of a Patient with an Unusual Factor VIII Inhibitor

A.L Bloom
1   Institute of Pathology and Medical Unit, Royal Infirmary, Cardiff
,
A.J Davies
1   Institute of Pathology and Medical Unit, Royal Infirmary, Cardiff
,
J.K Rees
1   Institute of Pathology and Medical Unit, Royal Infirmary, Cardiff
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

The clinical and laboratory features of a patient with a post-partum factor VIII inhibitor are described. A large sublingual haematoma caused respiratory distress but this was quickly relieved by treatment with bovine antihaemo- philic globulin. The inhibitor activity rapidly declined possibly because of corticosteroid therapy but factor VIII levels subsequently remained reduced.

Inactivation of factor VIII by the inhibitor in vitro increased on incubation but was incomplete and did not give the linear pattern described by Biggs and Bidwell (1). Although the clotting time of the patient’s blood was prolonged a factor VIII level of 18% was detected. The inhibitor was apparently more active when residual factor VIII was assayed by a one-stage than by a two- stage method and it inactivated similar proportions of factor VIII when this was added to plasma in different concentrations. Factor VIII could not be recovered from combination with the inhibitor by euglobulin precipitation. The results suggest that the inhibitor altered the reactivity of factor VIII.

A transiently positive direct antiglobulin test suggested an immunological basis for the syndrome but although the inhibitor showed some species specificity for human factor VIII no other supporting evidence was obtained.

 

  • References

  • 1 Biggs R, Biclwell E. A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Brit. J. Haemat 05: 379 1959;
    CrossrefPubMedGoogle Scholar
  • 2 Biggs R, Denson K. W. E. The fate of prothrombin and factors VIII, IX and X transfused to patients deficient in these factors. Brit. J. Haemat 09: 532 1963;
    CrossrefPubMedGoogle Scholar
  • 3 Biggs R, Denson K. W. E, Nossel H. L. A patient with an unusual circulating anticoagulant. Thrombos. Diathes. haemorrh. (Stuttg) 12: 1 1964;
    PubMedGoogle Scholar
  • 4 Biggs R, MacFarlane R. G. Human Blood Coagulation and its Disorders. 3rd ed.. Blackwell Scientific Publications; Oxford: 1962
    Google Scholar
  • 5 Bonnin J. A, Cohen A. K, Hicks N. D. Coagulation defects in a case of systemic lupus erythematosus with thrombocytopenia. Brit. J. Haemat 02: 168 1956;
    CrossrefPubMedGoogle Scholar
  • 6 Breckenridge R. T, Ratnoff O. D. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for antihemophilic factor. Blood 20: 137 1962;
    PubMedGoogle Scholar
  • 7 Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J. Biol. Chem 166: 189 1946;
    CrossrefPubMedGoogle Scholar
  • 8 Conley C. L, Hartmann R. C. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J. clin. Invest 31: 621 1952;
    PubMedGoogle Scholar
  • 9 Craddock Jr. C. G, Lawrence J. S. Hemophilia. A report of the mechanism of the development and action of an anticoagulant in two cases. Blood 02: 505 1947;
    PubMedGoogle Scholar
  • 10 Dausset J. Les anticoagulants circulants. Sont-ils des anticorps ? Sang 30: 428 1959;
    PubMedGoogle Scholar
  • 11 Deutsch E. Acquired inhibitors. Wright I. S, Koller F, Beck E. (eds.) Progress in Coagulation. 112 Schattauer; Stuttgart: 1962
    Google Scholar
  • 12 Dreskin O. H, Rosenthal N. A hemophilia-like disease with prolonged coagulation time and a circulating anticoagulant. Blood 05: 46 1950;
    PubMedGoogle Scholar
  • 13 Ellis H, Handley D. A, Taylor K. B. Surgery in a patient with an acquired circulating anticoagulant. Lancet I: 1167 1959;
    PubMedGoogle Scholar
  • 14 Evans D. M. D. Haemorrhagic diathesis due to a circulating anticoagulant investigated by the thromboplastin generation test. J. clin. Path 08: 168 1955;
    CrossrefPubMedGoogle Scholar
  • 15 Favre-Gilly J, Thouverez J. P. Les inhibiteurs de la première phase de la coagulation en dehors de l’hémophilie. Sang 30: 351 1959;
    PubMedGoogle Scholar
  • 16 Frommeyer Jr. W. B, Epstein R. D, Taylor F. H. L. Refractoriness in hemophilia to coagulation-promoting agents: whole blood and plasma derivatives. Blood 05: 401 1950;
    PubMedGoogle Scholar
  • 17 Hardisty R. M. Acquired haemophilia-like disease. Report of a case with studies on the mode of action of the circulating anticoagulant. J. clin. Path 07: 26 1954;
    PubMedGoogle Scholar
  • 18 Hicks N. D, Pitney W. R. A rapid screening test for disorders of thromboplastin generation. Brit. J. Haemat 03: 227 1957;
    CrossrefPubMedGoogle Scholar
  • 19 Horowitz H. I, Fujimoto M. M. Acquired hemophilia due to a circulating anticoagulant. Report of two cases with review of the literature. Amer. J. Med 33: 501 1962;
    PubMedGoogle Scholar
  • 20 Hougie C. Pseudo-haemophilia: an acquired haemorrhagic diathesis due to a circulating anticoagulant. J. clin. Path 06: 30 1953;
    CrossrefPubMedGoogle Scholar
  • 21 Knyvett A. F. Haemorrhagic disease due to a circulating anticoagulant, with report of a case. Aust. Ann. Med 01: 84 1952;
    PubMedGoogle Scholar
  • 22 Margolius Jr. A, Jackson D. P, Ratnojf O. D. Circulating anticoagulants: A study of 40 cases and a review of the literature. Medicine 40: 145 1961;
    CrossrefPubMedGoogle Scholar
  • 23 May J. R, Rawling G. A. A micro-method for agar-gel precipitin reactions. J. clin. Path 15: 186 1962;
    CrossrefPubMedGoogle Scholar
  • 24 Munro F. L. Properties of an anticoagulant found in the blood of a hemophiliac. J. clin. Invest 25: 22 1946;
    CrossrefPubMedGoogle Scholar
  • 25 Nussey A. M, Dawson D. W. Haemophilia-like disease due to an auto-antibody. Brit, me d.J II: 1077 1957;
    PubMedGoogle Scholar
  • 26 Penalver J. A, Holburn R. R, Carroll R. T, Baird H, Tocantins L. M. Are there antibodies against clotting factors in hemophilia “A” patients refractory to transfusion?. Brinkhous K. M. (ed.) Hemophilia and Hemophilioid Diseases. 57 University of 1ST. Carolina Press; Chapel Hill: 1957
    Google Scholar
  • 27 Pinkerton P. H. A circulating anticoagulant specifically active against antihaemophilic globulin. J. clin. Path 18: 122 1965;
    PubMedGoogle Scholar
  • 28 Pool J. G, Robinson J. Assay of plasma antihaemophilic globulin (AHG). Brit. J. Haemat 05: 17 1959;
    CrossrefPubMedGoogle Scholar
  • 29 Proctor R. R, Rapaport S. I. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Amer. J. clin. Path 36: 212 1961;
    PubMedGoogle Scholar
  • 30 Quick A. J, Stefanini M. Activation of plasma thromboplastinogen and evidence of an inhibitor. Proc. Soc. exp. Biol. (N. Y) 67: 111 1948;
    CrossrefPubMedGoogle Scholar
  • 31 Ratnoff O. D. Discussion on Penalver et al. (1957) 60 1957;
    PubMedGoogle Scholar
  • 32 Rosenthal M. C. A mechanism of plasma refractoriness in hemophilia. Brinkhous K. M. (ed.) Hemophilia and Hemophilioid Diseases. 51 University of N. Carolina Press; Chapel Hill: 1957
    Google Scholar
  • 33 Sise H. S, Gauthier J, Desforges J, Becker R. Spontaneous circulating anticoagulant (antifactor Y III). Case report and review of the literature. Amer. J. Med 32: 964 1962;
    PubMedGoogle Scholar
  • 34 Tzanck A, Soulier J. P, Blatrix C. h. Deux nouvelles observations de syndromes hémor- rhagiques avec présence d’un anticoagulant circulant (étude électrophorétique et thérapeutique). Rev. Hémat 04: 502 1949;
    PubMedGoogle Scholar
  • 35 Van Creveld S, Hoorweg P. G, Paulssen M. M. P. Researches on a circulating anticoagulant in a hemophiliac. Blood 06: 233 1951;
    PubMedGoogle Scholar
  • 36 Verstraete M, Vandenbrouke J. Occurrence and mode of action of endogenous circulating anticoagulants, J, lab. clin, Med 48: 673 1956;
    PubMedGoogle Scholar